Crowdonomics
BioScience Health Innovations, Inc.

Reg A+ · Equity · Dec 2025

OpenReg A+Equity
via the platform · last checked Aug 16, 2026
Raised
$0 / $1M max
0% of ceiling
Investors
—
—
Momentum
$0/day
—

Financials disclosed in this offering

FY2024 · hover for source
$1.8M
$87K
FY2024
RevenueNet income
Metric
FY2024 audited
Income statement
Revenue
$1,844,966
Cost of goods sold
$536,078
Gross margin
71%
Net income
$87,000
Taxes paid
$0
Balance sheet
Cash
$662,517
Accounts receivable
$100,285
Total assets
$873,788
Long-term debt
$0
Total liabilities
$38,548
Other
Headcount
0

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Jul 6, 2026
    • Maximum $1M → $5.8M
    • Price $1 → $4.5
    • Securities offered 1,000,000 → 1,884,382
    Form 1-A POS on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$11.4M
Price / share$1.00
Shares offered1,000,000

Estimated, not stated: $1.00 × 11,399,055 as-converted securities outstanding.

Offering details

Target—
Max$1,000,000
Min investment—
OpenedDec 4, 2025
Deadline—
Days active308

Links & provenance

Source: SEC EDGAR
0001185185-25-001854
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.